Get the app
USHealthcare

Ardent Health Partners, Inc. (ARDT)

US · Healthcare · Medical Care Facilities

$10.70-0.19%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$1.62B
Revenue YoY
-1.4%
Net profit
$16.9M
Profit YoY
-76.8%
EPS
$0.12
EPS estimate
$0.17
Net margin
1.0%

EPS came in at 0.12 against a street estimate of 0.17 — a miss of 29.4%.

Key statistics

Market cap
$1.54B
P/E
20.6
Forward P/E
10.0
P/B
1.16
Book value
$9.52
EPS (TTM)
$0.53
52-week high
$15.48
52-week low
$7.71
50-day MA
$10.73
200-day MA
$9.55
Beta
0.70

Analyst view

Analysts rate Ardent Health Partners, Inc. a buy (9 buy, 2 hold, 0 sell out of 11) with an average price target of $12.77.

Shareholding

Insiders
23.84%
Institutions
76.71%

Largest institutional holders

FundStake
Chai Trust Co., LLC54.77%
Ventas Inc6.62%
Ameriprise Financial Inc1.26%
BlackRock Inc1.25%
Goldentree Asset Management LP1.12%
CastleKnight Management LP0.76%
Vanguard Capital Management, LLC0.71%
AQR Capital Management LLC0.67%

Recent filings & reports

DocumentDate
Company announcement · Q3 2026
ARDENT HEALTH, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Adjusted EBITDA for 2025 revised downward from $545.0 million to $447.3 million — a reduct
2026-09-04
Quarterly report · Q2 2026
ARDENT HEALTH, INC. — 10-Q SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Total Revenue (6 months ended June 30, 2026): $3,224,115 thousand ($3.2 b
2026-08-10
Results announced · Q3 2026
ARDENT HEALTH, INC. — Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Total Revenue Q2 2026: $1,622 million (down 1.4% year-over-year) • Net Income Attri
2026-08-04
Board / officer change · Q2 2026
ARDENT HEALTH, INC. (ARDT) - FORM 8-K SUMMARY HEADLINE NUMBERS • Reporting Date: June 30, 2026 (Event Date: June 26, 2026) • Company: Ardent Health,
2026-06-30
Board / officer change · Q2 2026
ARDENT HEALTH, INC. - DOCUMENT SUMMARY HEADLINE NUMBERS • Dave Caspers appointed President and Chief Executive Officer effective June 2, 2026 • Annu
2026-06-02
Quarterly report · Q1 2026
ARDENT HEALTH, INC. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total Revenue (Q1 2026): $1,601.9 million vs. $1,497.2 million (Q1 2025) — +7.0% growt
2026-05-06
Proxy statement · Q2 2026
ARDENT HEALTH, INC. — 2026 PROXY SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect 11 directors to the Board • Proposal 2: Non-binding adv
2026-04-08
Annual report FY2025
ARDENT HEALTH, INC. – ANNUAL REPORT SUMMARY (FY 2025) HEADLINE NUMBERS • 30 acute care hospitals operating across 8 markets in 6 states (Texas, Okla
2026-03-16

Readable in the app.

Deals & corporate news

AnnouncementDate
Board authorizes $50 million stock repurchase program
Ardent Health announced a $50 million stock repurchase program authorized by its Board of Directors on November 17, 2025. The company can buy back its own shares through various methods incl
2025-11-18

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Ardent Health Partners, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.